The inaugural Emerging Spine Tech & Concepts course brought neurosurgery residents & fellows from the U.S. & Canada to Buffalo for hands-on learning. Thanks to our faculty, @jacobsinstitute, Atlas Surgery Center & sponsors, @globusmedical, @siboneinc, Acuity, icotec & @carlsmed.
At @UB_Neurosurgery, we continue to push the envelope not only for outpatient DSAs, but also for neuro-intervention. Here’s a patient that in the last month underwent MMA embolization using #Zebra@Q_Apel guide catheter and Onyx 18 @Medtronic at our ambulatory center.
#ANSC
Advanced neurosurgical care, close to home — and home the same day.
Atlas Ambulatory Neurosurgery Center (ANSC™) is redefining brain and spine surgery with cutting-edge endovascular tech, faster recovery, and strong collaboration with UB Neurosurgery.
Family planning in neurosurgery—let’s talk about it. Join our virtual event on Jan 20th, 7–8 PM CST, for an open discussion on balancing training, career goals, and family planning in neurosurgery.
🚨 CALL FOR ABSTRACTS!
The Latino Surgical Society invites you to submit your work for the 2026 Surgical Symposium at the University of Chicago.
🗓 Deadline JAN 9, 2025
📍 April 24–26, 2026 | Chicago, IL
https://t.co/uWvpvgmDhq
#LatinoSurgicalSociety#SurgicalSymposium2026
Gamma Knife Suite allows our surgeons to target deep-seated brain conditions with extreme precision without invasive surgery.
It's the first ambulatory neurosurgery center in the U.S. to offer this advanced treatment.
Learn more: https://t.co/44PHdlGNHl
History is being made in Buffalo once again; and I’m thrilled to be part of it. ✨
The first independently private Gamma Knife center in the US is now a reality at ATLAS.
Excited to keep advancing research in this field, with gratitude to Dr. Moreland for the opportunity. 🧠
New article!🚨
🧠 Latin America needs 924 more neurosurgeons. 40% of the population lives >2hrs from neurosurgical care.
Our new paper proposes a regional framework: shared training, resource redistribution & multicenter research.
The infrastructure exists.
Time to act. 🌎
Help Us Improve Clinical Trials for Glioblastoma Patients!
The Pennsylvania State University invites you to participate in a research study to better understand the perspectives of patients and caregivers regarding clinical trials for glioblastoma and high-grade gliomas. Your input will guide future treatment approaches and enhance patient-centered care.
Who Can Participate?
Adults aged 18 or older who are:
Diagnosed with glioblastoma or high-grade glioma, OR
Caregivers of someone with glioblastoma or high-grade glioma.
What's Involved?
Complete an anonymous online survey that takes about 5 minutes to 15 minutes of your time.
The survey will include questions about:
Your experiences as a patient or caregiver.
Your treatment priorities.
Your views and preferences regarding clinical trials.
Why Participate?
Your participation can:
· Help researchers understand what matters most to patients and caregivers.
· Contribute to improving clinical trial designs and advancing glioblastoma research.
How to Participate?
Join now! Participation is voluntary, anonymous, and confidential. Access the survey via the link or QR code below.
https://t.co/CYXfK6JTUE
Make a Difference in Glioblastoma Research
Thank you for considering this opportunity to make a difference in healthcare innovation!
@AsgeirJakola@WeTrialshub